Status:
RECRUITING
Robotic Versus Laparoscopy NOSE for Stage I-III Left-sided Colon Cancer
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this project, the investigator aims to provide the level 1 evidence for the comparison of robotic versus laparoscopic NOSE for the surgery of stage I-III colorectal cancer. the investigator hypothe...
Detailed Description
Over the past three decades, laparoscopic surgery has evolved incessantly, especially in the field of colorectal surgery. It has been widely accepted by surgeons and patients in light of the better pe...
Eligibility Criteria
Inclusion
- Primary colon cancers located at the left sided colonic anatomic location, including distal transverse colon, colonic splenic flexure, descending colon, sigm oid descending colonic junction, sigmoid colon and upper rectum that required the mobilization of colonic splenic flexure to facilitate a curative resection and trans anal specimen extraction ;
- TNM Stage I III adenocarcinomas;
- Curative and elective surgery;
- American Society of Anesthesiology (ASA) class I to III patients;
- Age \>18 years.
Exclusion
- Cecal, ascending, the proximal and middle transverse colon cancers; and the middle or lower rectal cancers;
- Emergency or palliative surgery;
- Evidence of disseminated disease or adjacent organ invasion;
- Primary tumor mass \>8 cm in diameter;
- Morbidly obese patients, that is, body mass index (BMI) ≥40 kg/m 2 ;
- Previous major surgery of upper abdomen or pelvis
Key Trial Info
Start Date :
April 7 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 6 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05970133
Start Date
April 7 2023
End Date
October 6 2025
Last Update
September 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100